Infection of C3H/He mice with the Peruvian strain of
Necrosis of different cells and tissues is a prominent finding seen in acute Trypanosoma cruzi infection. It involves parasitized macrophages, cardiac and skeletal muscles cells in different animal species such as mice, dogs, and Callomys callosus (Andrade 1991 , Cordeiro et al. 1997 , Magalhães-Santos et al. 2004 . In acute Chagas' disease in humans, necrosis of cardiac myocells, either containing intracellular forms of T. cruzi or in the absence of parasites, constitutes an outstanding feature in advanced acute chagasic myocarditis (Andrade 1991) . In experimental studies (Cordeiro et al. 1997 ) it was demonstrated extensive focal necrosis of the spleen, involving macrophages and the intracellular parasites, related with high and early mortality of the animals and a rapid drop of parasitemia in mice infected with the Y strain of T. cruzi. In a previous study we have investigated the in situ participation of TNF-a in cellular necrosis and destruction of parasitized macrophages in the spleen, during the infection with a macrophagotropic strain of T. cruzi (Lima et al. 2001) . By immunohistochemical identification of that cytokine it was shown that TNF-a was expressed in focal necrotic areas within the germinal centers and red pulp of the spleen, indicating a pivotal importance of that cytokine in the exacerbation of tissue lesions. Activation of macrophages by intracellular parasites can stimulate their trypanocidal mechanism with production of TNF-a and toxic oxygen metabolites, especially nitric oxide (NO) (Gazzinelli et al. 1992 , Silva et al. 1995 . T. cruzi is a potent priming agent for TNF-a production by splenic cells in vitro (Tarleton et al. 1988 ). According to Dos-Reis (1997) , cytokine production by stimulated macrophages, including TNF-a, can be helpful for the control of parasitemia, but also induces toxic lesions, leading to death. According with Truyens et al. (1999) the parasitemic phase of T. cruzi infection in mice is associated with high levels of circulating TNF-a. Besides playing a beneficial role early in infection, TNF-a also triggers harmful effects in the parasitemic phase, which are limited by the in vivo simultaneous endogenous production of soluble receptors (Truyens et al. 1999) . Studying the role of IL-10, TGF-b, IFN-g and TNF-a, regulating chemokine production and expression in IFN-g or TNF-R1-p55 deficient mice infected with T. cruzi, Aliberti et al. (2001) suggested an important role for IFN-g and TNF-a in the control of chemokine expression and production in experimental T. cruzi infection.
To further evaluate the role of TNF-a on the necrotic lesions and in the evolution of infection, revealed by the parasitemic levels and mortality in the experimental animal, we evaluated the effect of the inhibition of this cytokine by the use of pentoxifylline (PTX) an inhibitor of TNF-a. PTX is a methylxantine derivative, with multiple properties and clinical use, as reviewed by Ward and Clissold (1987) and by Samlaska and Wimfield (1994) . Some studies indicate that this drug suppresses TNF-a production by monocytes, and inhibits leucocyte stimulation by TNF-a and IL-1 (Sullivan et al. 1988 , Bernard et al. 1995 , Mandell 1995 . Treatment with PTX has been also performed in patients with severe cerebral malaria (Wenisch et al. 1998) , with the objective of to inhibit the action of TNF-a, with improvement of the clinical picture in treated patients.
In the present study, treatment with PTX has been assayed in mice infected with a macrophagotropic strain of T. cruzi, the Peruvian strain (Ps) (Andrade & Magalhães 1997) to evaluate the influence of such treatment upon the course of infection, the parasitemia and mortality. The presence of necrosis of the spleen and the influence of PTX treatment in the expression of TNF-a in the spleen lesions were also evaluated by histopathological and immunohistochemical study.
The quantitative evaluation of TNF-a expression in necrotic lesions showed a significant decrease in treated animals, corresponding to decreased parasitemia. These findings could indicate an influence of this cytokine in the severity of acute infections with T. cruzi, and a possible control of the lesions by treatment with PTX.
MATERIALS AND METHODS
Experimental animal -C3H/He inbred mice, weighing 10 to 15 g, raised in the animal facilities of the Centro de Pesquisas Gonçalo Moniz-Fiocruz, were used in the present study. Their maintenance complied with the guidelines for the human use of laboratory animals.
T. cruzi strain -The Ps of T. cruzi, a macrophagotropic strain (Andrade & Magalhães 1997 ) (Biodeme type I, Z2b), was inoculated by intraperitoneal route. The inoculum represented 1x10 5 blood forms to 10 g of body weight.
Experimental groups -64 C3H/He mice, were divided into four groups: group A -24 mice infected with the Ps; group B -25 mice infected with this strain and treated with PTX; group C-10 uninfected mice treated with PTX; group D-5 intact controls.
Follow up of the experimental groups -Parasitemia was daily evaluated during the course of infection in five mice of each infected group and expressed as the means of parasites in peripheral blood counted in 50 microscopic fields (400X). Cumulative mortality was evaluated by daily counting of dead mice, excluding those previously sacrificed. The mortality rate was registered up to the 12th day post infection.
Treatment with PTX [1-(5-oxo-hexyl)-3, 7 dimethylxantine] -This drug was used in phosphate buffer solution (PBS)
, by intra-peritoneal injections. It was administered from the 3rd day of infection, in two daily doses of 30 mg/kg/bw every 12 h. Treatment was performed until the last day of survival, i.e. the 13th day. Bioavailability of this drug: according with pharmaceutical indications (SanofiAventis Pharmaceutic Ltda), Trental® Vert is rapidly absorbed and its liberation is maintained for 10 to 12 h with constant levels during this period of time. Two daily doses every 12 h has been previously used by others (He & Sharma 2005) , intraperitoneally, without harmful effects.
Three mice from each experimental group were killed by exsanguination under halotane anesthesia in the 5th, 7th, 8th, 10th, 11th and 12th days after infection. Still alive, the animals were submitted to spleen perfusion, after section of the portal vein, by injection with cold PBS through the left ventricle of the heart. Complete necropsies were performed and fragments of the spleen, liver, heart and skeletal muscles were fixed into buffered formalin (Milloning fixative), followed by paraffin embedding. Sections were stained with hematoxylin and eosin for histopathological study.
Fragments of the spleen were embedded in tissueteck (OCT compound-Miles Inc. Diagnostic Division, Elkhart, USA) frozen in liquid Nitrogen and cryopreserved in a freezer at -70 o C. Sections of 6 mM were cut in a cryostat at -10 o C, fixed in dehydrated acetone and treated with PBS containing 0.1% Saponin (Sigma St Louis, MO, USA) and 1% bovin serum albumin (BSA) (Sigma). For blocking non-specific binding, sections were treated with 39% BSA in PBS for 20 min at room temperature. Sections were incubated overnight at 4 o C in a humidified chamber with rat IgG anti-mouse -TNF-a antiserum (MPC-XT3) (Pharmigen, San Diego, CA, USA) diluted 1:50 in PBS pH 7.4/saponin 0.1%/BSA 1%. After washing with PBS and saponin, sections were incubated in normal sheep serum, for 20 min for additional blocking of non-specific binding. The slides were then incubated for 30 min at 37 o C in a humidified chamber with sheep-antirat IgG antibody conjugated to peroxidase (BoehringerMannheim Biochemica, Germany) diluted 1:1000 in PBS. Inhibition of the endogenous peroxidase was achieved by a 30 min incubation in 0.3% H 2 O 2 at room temperature. The colour was developed with 0.06% 3, 3´-diaminobenzidine tetrahydrocloride (DAB) (Sigma) and 0.06% H 2 O 2 plus 1% dimethylsulfoxide (Sigma). Sections were counterstained with 1% methyl-green for 2 min, dehydrated and mounted with Permount.
Positive control -Cells of the lineage J774 described as "macrophage like" (Ralph & Nakoinz 1975 , Van Furth et al. 1985 were maintained in RPMI cell culture medium with 10% bovine foetal serum and collected during the exponential phase growth. They were stimulated for 24 h with 10 mg/ml lipopolysacharide (LPS) from the cellular membrane of Escherichia coli (Sigma) in CO 2 chamber, at 37 o C. Stimulated cells were centrifuged at 1.500 rpm for 10 min 4 o C, washed with RPMI and centrifuged a second time at 1.500 rpm for 10 min. The pellet was suspended in PBS at a concentration of 10 6 cells/ml, and re-centrifuged (Cytospin-3-Shandon, Life Sciences International, England) for adhesion to slides previously treated with Poly L-lisine.
Negative control -Normal rat serum from a diluted 1: 300, was used in substitution of the primary antibody (rat IgG antimouse TNF-a).
Morphometry -Quantitative evaluation of the necrotic areas in the germinal centers of the lymphoid follicles immunolabeled for TNF-a was performed in the mice both in untreated control and in the mice treated with PTX. For evaluation of the necrotic areas with positive labeling for TNF-a a total area of 213.0 mm 2 was examined in each case (five fields of 42.6 mm 2 ) being six mice from each group. For all semi-automated morphometry, an optical microscope (Zeiss) was used and the images were captured and evaluated using the program Axio Vision 3.1 (1998) (1999) (2000) (2001) (2002) (Carl Zeiss Vision GmbH, Germany) .
Statistical analysis -Comparative non-parametric Mann-Whitney test was used with the significance level of p < 0.05. Fig. 1 evolution of parasitemia in the group A (infected untreated mice) showed the profile of the Biodeme type I, with an early parasitemic peak at the 8th day post-infection. A difference was observed in the parasitemic evolution in the mice treated with PTX (B) showing a delayed increasing of the parasitemia with the higher peak by 12 days of infection.
RESULTS

Parasitemia -As depicted in
Cumulative mortality -In the infected untreated group (A), 100% of the mice died until the 12th day of infection; in the group B (treated with PTX), 100% of mortality was attained in the 13th day of infection (Fig. 2) .
Histopathological study of the spleen -Group A: infection with T. cruzi determined a reactional state of the lymphoid follicles, with prominent germinal centers, with hyperplastic and vacuolated macrophages, containing amastigotes of T. cruzi. In untreated controls, necrosis of parasitized macrophages and of other cells of the spleen was present in the germinal centers, from the 7th day of infection, being more intense in the 10th and 11th day post-infection (Figs 3A,C,E); group B: treatment with PTX determined a decrease of the size and intensity of necrotic lesions and of the reactive state of lymphoid follicles. A diminution of hyperplasia and parasitism of macrophages, as compared with infected, untreated control mice was also present (Figs 3B, D, F); group C: histology of the spleen and liver taken from uninfected mice treated with PTX disclosed no alterations; group D: intact controls, showed essentially normal splenic structure.
Immunohistochemistry -Evaluation of the presence of TNF-a in necrotic areas of the spleen-Positive control: J774 cells, treated with monoclonal anti-TNF-a antibody, represented the positive result (Fig. 4A) ; negative control: spleen sections of infected mouse, submitted to all steps for immunolabeling, excluding the primary antibody, presented negative reaction (Fig. 4B) ; group A-Infected untreated controls: staining with anti-TNF-a monoclonal antibody revealed positive staining of necrotic areas of the germinal centers, involving macrophages, disintegrated parasites and splenic tissue. TNF-a was present in a moderate degree from the 7th through the 9th day, but became more marked from the 10th to the 11th day post-infection ( Figs 4C, E) ; group B-Infected mice treated with PTX: immunolabeling with anti-TNF-a monoclonal antibodies, revealed moderate positive reaction in the 7th and 8th day post-infection (corresponding to the period of four to five days following the beginning of treatment) (Fig. 4D) ; cases examined at the 9th and 11th day post-infection (six to eight days after the beginning of treatment), presented negative results for TNF-a immunolabeling. Focal areas with disintegrated parasites were seen devoid of TNF-a labeling (Fig. 4F) .
Morphometry -Results of evaluation of the necrotic areas immunolabeled for TNF-a: Quantitative evaluation of necrotic areas of the germinal centers of lymphoid follicles, with positive expression of TNF-a, revealed significant differences (p = 0.04) between the groups A and B. In the infected untreated group, most of the necrotic areas were positive for TNF-a, considering the total area of 42.6 mm 2 examined for each case. A significant predominance in the size of these areas in the control group (A) as compared with the treated with PTX (B), was detected (Fig. 5) .
DISCUSSION
Results of the present investigation demonstrate an important influence of PTX in the control of macrophage activation and production of TNF-a in situ in the spleen of C3H/He inbred mice infected with the macrophagotropic Ps of T. cruzi. Due to the high virulence of the Ps (Biodeme type I) conjugated with the high susceptibility In the group A (untreated controls), the profile of Biodeme type I strains is reproduced, with highest peak in the 8th day of infection; in group B, (treated with pentoxifylline) parasitemic evolution is delayed, with highest peak in the 12th day of infection. of the mice lineage (C3H/He), the course of infection was rapid and the parasitemia attained their maximum level in the lapse of four days, from the 8th to the 12th day. Differences occurring during this period were considered as significant. Even when we compare mouse lineages with different degrees of susceptibility this behaviour of biodeme type I strains is maintained (Andrade et al. 1985) . However, in the present study, considering the mortality of treated mice, a delay of one day on the survival time could not be considered as biologically significant. The action of PTX was evidenced by a decrease in necrotic areas presenting TNF-a, which was confirmed by computorized morphometry. Macrophage activation was diminished, as revealed by less hyperplasia and vacuolization when compared to controls. That was probably a result from a down regulation of microbicidal responses of macrophages, by PTX. According with Reed and DeGowin (1992) , PTX has an influence in the natural killer (NK) cells activity probably inhibiting the production of IFN-g responsible for the activation of macrophages; a paradoxical effect was the diminished parasitism of macrophages. However experimental studies on leishmaniasis due to Leishmania amazonensis (Sá de Oliveira et al. 2000) demonstrate that treatment with PTX reduced macrophages vacuolization, with a more effective destruction of parasites by these cells. Infection with T. cruzi induces an innate response and stimulates NK T cells to produce IFN-g (Cardillo et al. 1996) . That cytokine can stimulate macrophages to produce type1 (proinflammatory) cytokines, such as IL-12, TNF-a and IFN-g, and to liberate microbicidal agents such as N and O metabolites: NO and H 2 O 2 (Gazzinelli et al. 1992 , Silva et al. 1995 , Dos-Reis 1997 . This complex microbicidal reaction, could be helpful in controlling parasitemia, but on the other hand, may also provoke toxic lesions, leading to the death of the animals (Dos-Reis 1997). The C3H/He inbred mice are, characteristically, very susceptible to infection, both by myotropic and macrophagotropic strains of T. cruzi (Andrade et al. 1985) . Investigations on the kinetics of macrophage activation by infection with T. cruzi, demonstrate that macrophages of susceptible mice produce higher levels of TNF-a, than the macrophages of resistant mice, according to Russo et al. (1989) and Starobinas et al. (1991) . These findings confirm the importance of the mouse genetic background in the relationship of immunological responses to infec- tion and the expression of TNF-a. Previous study on the presence of TNF-a in the necrotic areas (Lima et al. 2001) have shown the predominance of these lesions in the C3H (highly susceptible mice strain), in comparison with Swiss and DBA strains that are more resistant to T. cruzi infection.
Besides macrophages, other tissue cells, such as cardiac myocells, when infected with T. cruzi produce several regulatory cytokines, as shown by Teixeira et al. (2002) According to Mandell (1995) , the anti-inflammatory effect of PTX inhibits the host tissue damage by activated macrophages, by reduction of inflammatory cytokines (especially TNF-a) and by reversal of the effect of these cytokines on phagocytes. The effect of PTX on human monocytes has been investigated (Marques et al. 1999) and it has been shown that in pulmonary sarcoidosis, PTX inhibit, in vitro, the spontaneous TNF-a production by alveolar macrophages. Using another experimental model, Doherty et al. (1991) investigated the effect of PTX on endotoxin-stimulated TNF production in vitro and in vivo and showed that PTX inhibited TNF production by murine adherent peritoneal exsudated cells incubated with endotoxin; similarly it decreased the number of available TNF messengers RNA transcripts in peritoneal exsudates (Doherty et al. 1991) . In human acute Chagas' disease, necrotic lesions of myocytes, especially the cells of the conduction tissue of the heart, represents an aggravating factor of the disease (Andrade & Miziara 1983) . Considering the severity of acute Chagas' disease in humans, with necrotic-inflammatory lesions of the heart, it seems important to investigate the anti-TNF-a action of PTX in experimental T. cruzi infection. The results could provide a coadjuvant to the treatment of acute Chagas' disease, with the objective of diminishing the harmful effects of TNF-a to cardiac cells.
